Active Ingredient: dulaglutideDosage Forms & Strengths: Injection: 0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, 4.5 mg/0.5 mL solution in a single-dose pen Mechanism of Action: GLP-1 receptor agonistFirst Approval: US (Sep 18, 2014), EU (Nov 25, 2014) Revenue Analysis1Trulicity is used for the treatment of type 2 diabetes and to reduce the risk…
